MEDICO, Enzo
 Distribuzione geografica
Continente #
NA - Nord America 12.108
EU - Europa 6.497
AS - Asia 4.101
OC - Oceania 90
SA - Sud America 53
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 20
Totale 22.917
Nazione #
US - Stati Uniti d'America 11.923
CN - Cina 2.466
IT - Italia 2.109
DE - Germania 759
IE - Irlanda 575
SE - Svezia 484
GB - Regno Unito 430
FR - Francia 375
SG - Singapore 362
FI - Finlandia 348
JP - Giappone 305
AT - Austria 304
UA - Ucraina 258
KR - Corea 237
PL - Polonia 177
IN - India 172
VN - Vietnam 156
CA - Canada 152
BE - Belgio 117
NL - Olanda 114
HK - Hong Kong 106
TW - Taiwan 88
ES - Italia 87
DK - Danimarca 85
AU - Australia 79
CH - Svizzera 50
BR - Brasile 38
RU - Federazione Russa 38
TH - Thailandia 37
RO - Romania 34
TR - Turchia 33
IR - Iran 31
MX - Messico 28
NO - Norvegia 26
SN - Senegal 26
PT - Portogallo 23
GR - Grecia 22
CZ - Repubblica Ceca 20
MY - Malesia 18
EU - Europa 17
ID - Indonesia 17
IL - Israele 14
NZ - Nuova Zelanda 11
PK - Pakistan 11
HU - Ungheria 10
PH - Filippine 9
CL - Cile 8
UZ - Uzbekistan 8
ZA - Sudafrica 8
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 6
BA - Bosnia-Erzegovina 5
LU - Lussemburgo 5
SA - Arabia Saudita 5
AL - Albania 4
BN - Brunei Darussalam 4
BY - Bielorussia 4
CO - Colombia 4
EG - Egitto 4
HR - Croazia 4
JO - Giordania 4
LK - Sri Lanka 4
MO - Macao, regione amministrativa speciale della Cina 4
NG - Nigeria 4
A1 - Anonimo 3
BG - Bulgaria 3
EE - Estonia 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AR - Argentina 2
DM - Dominica 2
GE - Georgia 2
KZ - Kazakistan 2
LT - Lituania 2
MK - Macedonia 2
BW - Botswana 1
CU - Cuba 1
GH - Ghana 1
GL - Groenlandia 1
HN - Honduras 1
IM - Isola di Man 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NA - Namibia 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 22.917
Città #
Ann Arbor 2.512
Chandler 1.106
Fairfield 907
Beijing 801
Houston 727
Ashburn 576
Dublin 556
Torino 475
Woodbridge 423
Seattle 377
Cambridge 339
Wilmington 338
Shanghai 280
Vienna 265
Dearborn 253
Singapore 223
Redwood City 217
Nyköping 204
Pisa 204
Villeurbanne 180
Jacksonville 170
Medford 164
Princeton 153
Guangzhou 150
Warsaw 142
Turin 135
New York 119
Milan 117
Tokyo 108
Hangzhou 102
Nanjing 102
Lappeenranta 94
Dong Ket 89
Fremont 79
Boardman 69
Wuhan 69
Boston 67
Brussels 67
San Diego 66
Rome 57
Taipei 55
Genoa 54
Shenyang 46
Helsinki 44
Toronto 43
Eitensheim 40
Los Angeles 40
Munich 39
Amsterdam 38
Chengdu 37
London 37
Ottawa 37
Changsha 36
Hong Kong 36
Phoenix 36
Norwalk 35
Zhengzhou 34
Nanchang 32
Santa Clara 32
Paris 30
Verona 29
Xian 29
Falls Church 28
Jinan 27
Kunming 27
Washington 27
Bangkok 26
Buffalo 26
Fuzhou 26
Silver Spring 25
Chongqing 24
Seoul 24
Melbourne 22
Southend 22
Mountain View 21
Bologna 20
Hefei 20
Belfast 19
Berlin 19
Florence 19
Düsseldorf 18
Central District 17
Heidelberg 17
Bengaluru 16
Hyderabad 16
Naples 16
Oslo 16
Shenzhen 16
Tianjin 16
Upper Marlboro 16
Barcelona 15
Moscow 15
Rochester 15
Central 14
Chicago 14
Harbin 14
Carrara 13
Guiyang 13
New Delhi 13
Pittsburgh 13
Totale 14.646
Nome #
Stromal contribution to the colorectal cancer transcriptome. 1.833
Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer 735
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 698
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer 652
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 617
Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer 564
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology 551
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. 503
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets 483
MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. 377
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients 365
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 326
Patient-derived xenografts and matched cell lines identify pharmacogenomic vulnerabilities in colorectal cancer 322
MicroRNA–mRNA interactions underlying colorectal cancer molecular subtypes 291
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 279
BRAF V600E is a determinant of sensitivity to proteasome inhibitors. 269
The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer. 245
Only a subset of Met-activated pathways are required to sustain oncogene addiction 238
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions 235
Truncated RAF kinases drive resistance to MET inhibition in MET-addicted cancer cells. 234
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 228
Transcriptional hallmarks of noonan syndrome and noonan-like syndrome with loose anagen hair 220
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 220
Met-driven invasive growth involves transcriptional regulation of Arhgap12 219
Transgenic models of cardiac cachexia and cardiac effects of muscular atrophy 218
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis 217
Analisi del profilo di trascrizione genetica nella sindrome di Noonan. 216
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 209
Inhibition of Src impairs the growth of met-addicted gastric tumors. 206
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 205
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 204
The MET oncogene is a functional marker of a glioblastoma stem cell subtype. 202
Evolving neoantigen profiles in colorectal cancers with DNA repair defects 198
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin 194
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells 193
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer. 187
Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18 F-FDG PET and MRI radiomics features 183
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies 182
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells 178
Sustained Met signalling in the heart leads to cardiac compensated hypertrophy and remodelling, which evolves into congestive heart failure 176
Exploiting orthologue diversity for systematic detection of gain-of-functionphenotypes 174
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK positive anaplastic large cell lymphoma. 173
Electrical conditioning of adipose-derived stem cells in a multi-chamber culture platform 173
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts 171
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma 169
Detection of gene communities in multi-networks reveals cancer drivers 169
A molecularly annotated model of patient-derived colon cancer stem-like cells to assess genetic and non-genetic mechanisms of resistance to anti-EGFR therapy 169
Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature 168
Mulcom: a multiple comparison statistical test for microarray data in Bioconductor 168
Isolation and Characterization of a Spontaneously Immortalized Multipotent Mesenchymal Cell Line Derived from Mouse Subcutaneous Adipose Tissue 161
A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart 155
A diphtheria toxin resistance marker for in vitro and in vivo selection of stably transduced human cells 153
Generation of Functional Hepatocytes from Mouse Germline Cell-derived Pluripotent Stem Cells in vitro 152
Patient-derived xenografts (PDXs) as model systems for human cancer 152
Semalytics: a semantic analytics platform for the exploration of distributed and heterogeneous cancer data in translational research 149
IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas 147
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models. 143
Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers 142
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study 139
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies 134
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 133
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles 133
PDX-MI: Minimal information for patient-derived tumor xenograft models 130
Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes 126
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. 125
Knock-in of oncogenic mutations in human somatic cells as a tool to identify genoselective compounds 124
Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. 123
A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis. 123
Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling 119
Amplification of repeat-containing transcribed sequences (ARTS): a transcriptome fingerprinting strategy to detect functionally relevant microsatellite mutations in cancer. 118
Formalin fixation at low temperature better preserves nucleic acid integrity. 114
Transcriptional signature of Pseudomyxoma Peritonei: An enhancement of treatment strategy and outcome prediction 114
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 114
The miR-126 regulates Angiopoietin-1 signaling and vessel maturation by targeting p85β 108
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES 106
Gene expression profiling of HGF/Met activation in neonatal mouse heart 105
A gene trap vector system for identifying transcriptionally responsive genes 103
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib 100
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 100
Reverse signaling by semaphorin 4C elicits SMAD1/5- And ID1/3-dependent invasive reprogramming in cancer cells 99
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer 99
Genome-wide analysis of unliganded estrogen receptor binding sites in breast cancer cells 96
Cancer and blood coagulation 95
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 95
Biochemical and immunological properties of the human carcinoma-associated CAR-3 epitope defined by the monoclonal antibody AR-3. 94
Biochemical and immunological properties of the human carcinoma antigen CAR-5 defined by the monoclonal antibody BD-5. 94
Modeling tumor progression and identifying genotype-drug interactions by the sequential introduction of cancer mutations into the genome of human normal cells 91
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 91
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation 91
Mek1 inhibition in vivo mitigates progressive cardiac concentric hypertrophy promoted by activated Met receptor. 90
Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power 88
The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. 86
The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma. 81
Structural and functional domains critical for constitutive activation of the HGF-receptor (Met). 80
Anaplastic large-cell lymphoma 80
The heme exporter FLVCR1a modulates the tricarboxylic acid cycle: a new target in colorectal cancer 78
The MET oncogene drives a genetic programme linking cancer to haemostasis 77
Unveiling the pathogenetic role of Stat3 in human lymphoma 76
Molecular anatomy of peripheral T cell lymphomas 76
Ionizing radiation fosters cancer invasion through transcriptional up-regulation of the MET oncogene 75
Totale 21.083
Categoria #
all - tutte 53.264
article - articoli 0
book - libri 0
conference - conferenze 6.131
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.395


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.163 0 0 219 460 272 609 354 263 340 295 200 151
2020/20213.030 173 191 261 188 223 249 301 170 265 292 196 521
2021/20224.747 480 426 408 493 359 332 418 343 220 218 615 435
2022/20233.553 365 295 102 329 324 735 222 259 451 96 217 158
2023/20242.404 247 278 142 162 163 303 157 226 56 213 239 218
2024/2025352 135 217 0 0 0 0 0 0 0 0 0 0
Totale 23.463